No insider purchase over the last 90 days. The latest was filed 21 Dec 2021.
Aemetis, Inc, classified in the Chemicals & Materials sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). In the past year (18 October 2025 to 18 October 2026), 9 filings came from 7 insiders.
No insider bought on the market over the period, while 1 insider filed 1 sale. The totals do not cover 1 filing with an undisclosed amount.
Across the 5,816 companies tracked on its exchange, the median is 19 filings; at 9 filings, this issuer sits below that mark. Looking back to 2021, when coverage begins, insiders filed 1 purchase and 10 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 197.6 m USD and net income at -77.0 m USD.
Typically, a trade is published a median of 6 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
For comparison within the same sector, see the insider buying recorded at Culp Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 84 declarations
Aemetis, Inc. (NASDAQ: AMTX) is a U.S.-based renewable fuels and low-carbon biochemicals company headquartered in Cupertino, California, United States. Founded in 2006 by Eric McAfee, the company has positioned itself as an integrated clean-energy industrial platform focused on displacing petroleum-derived products with renewable alternatives and monetizing environmental attributes where possible.
Aemetis’ business model spans several related operating segments. Its core asset base includes a California ethanol plant in the Central Valley near Modesto/Keyes, which produces fuel ethanol and valuable co-products used in animal feed. The company is also building and operating a California dairy RNG platform, consisting of biogas digesters and pipeline infrastructure that capture methane from dairy waste and convert it into Renewable Natural Gas. In addition, Aemetis is developing next-generation decarbonization projects such as Sustainable Aviation Fuel, Renewable Diesel, and Carbon Capture and Sequestration. Outside the United States, the group also has an India-based biodiesel operation producing biodiesel and refined glycerin for domestic and export customers.
From a competitive standpoint, Aemetis sits at the intersection of renewable fuels, waste-to-energy, and industrial decarbonization. Its investment case is driven by a combination of operating assets, project development optionality, and exposure to policy support, environmental credits, and low-carbon fuel markets. For investors, this also means the stock carries meaningful execution, commodity, regulatory, and financing risk. The company is not a large-cap utility-like stable operator; it is a development-heavy renewable energy platform with significant upside if projects ramp successfully, but also elevated sensitivity to capital markets and project timing.
Recent developments have centered on continued scaling of the company’s California Ethanol and Dairy Renewable Natural Gas businesses, along with a restart of biodiesel deliveries in India following operational interruptions. In 2025, Aemetis also reported receiving proceeds from the sale of federal clean energy tax credits, which is relevant to its liquidity and project funding profile. Company updates throughout 2025 emphasized ongoing investments to reduce the carbon intensity of its ethanol operations and to expand dairy digester capacity. Headquartered in the United States and listed on the NASDAQ, Aemetis is best understood as a thematic clean-energy growth story with a multi-asset platform, active project pipeline, and a material dependence on favorable policy and financing conditions.
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2025 | 197.6 m USD | -77.0 m USD | -1.28 USD | 10-K |
| Dec 2024 | 267.6 m USD | -87.5 m USD | -1.91 USD | 10-K |
| Dec 2023 | 77.2 m USD | -46.4 m USD | -1.22 USD | 10-K |
| Dec 2022 | 28.1 m USD | -107.8 m USD | -3.12 USD | 10-K |
| Dec 2021 | 211.9 m USD | -47.1 m USD | -1.54 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.